MD2849F1 - Method of mammary cancer treatment to patients of old age - Google Patents

Method of mammary cancer treatment to patients of old age Download PDF

Info

Publication number
MD2849F1
MD2849F1 MDA20050133A MD20050133A MD2849F1 MD 2849 F1 MD2849 F1 MD 2849F1 MD A20050133 A MDA20050133 A MD A20050133A MD 20050133 A MD20050133 A MD 20050133A MD 2849 F1 MD2849 F1 MD 2849F1
Authority
MD
Moldova
Prior art keywords
patients
cancer treatment
old age
mammary cancer
solution
Prior art date
Application number
MDA20050133A
Other languages
Romanian (ro)
Other versions
MD2849G2 (en
Inventor
Vasile Jovmir
Vitalie Machidon
Original Assignee
Vasile Jovmir
Vitalie Machidon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasile Jovmir, Vitalie Machidon filed Critical Vasile Jovmir
Priority to MDA20050133A priority Critical patent/MD2849G2/en
Publication of MD2849F1 publication Critical patent/MD2849F1/en
Publication of MD2849G2 publication Critical patent/MD2849G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Inventia se refera la medicina, in special la oncologie si poate fi utilizata pentru tratamentul cancerului mamar la pacientele de varsta inaintata cu patologii concomitente severe cardiovasculare, neurologice etc. Esenta inventiei consta in aceea ca se infiltreaza local in regiunea tumorii un amestec de solutie de lidocaina de 0,2% in cantitate de 150...200 ml si solutie de 5-fluorouracil in cantitate de 750 mg/m2, apoi se efectueaza interventia chirurgicala si se sutureaza plaga pe straturi.The invention relates to medicine, in particular to oncology and can be used for the treatment of breast cancer in elderly patients with severe concomitant cardiovascular, neurological and other pathologies. The essence of the invention is that a mixture of 0.2% lidocaine solution in quantity of 150 ... 200 ml and 5-fluorouracil solution in quantity of 750 mg / m2 is infiltrated locally in the tumor region, then the intervention is performed surgical and suture wound on the layers.

MDA20050133A 2005-05-16 2005-05-16 Method of mammary cancer treatment to patients of old age MD2849G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050133A MD2849G2 (en) 2005-05-16 2005-05-16 Method of mammary cancer treatment to patients of old age

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050133A MD2849G2 (en) 2005-05-16 2005-05-16 Method of mammary cancer treatment to patients of old age

Publications (2)

Publication Number Publication Date
MD2849F1 true MD2849F1 (en) 2005-09-30
MD2849G2 MD2849G2 (en) 2006-04-30

Family

ID=35057540

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050133A MD2849G2 (en) 2005-05-16 2005-05-16 Method of mammary cancer treatment to patients of old age

Country Status (1)

Country Link
MD (1) MD2849G2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3772G2 (en) * 2008-05-12 2009-07-31 Общественное Медико-Санитарное Учреждение Онкологический Институт Method for treating mammary cancer with metastases
MD24Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method of differential treatment of noninvasive mammary carcinoma
MD36Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method for differential treatment of noninvasive ductal carcinoma in situ of mammary gland
MD23Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method of differential treatment of noninvasive lobular mammary carcinoma in situ
MD35Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD106C2 (en) * 1993-11-12 1995-06-30 Онкологический Институт Республики Молдова Method of treatment for mamma cancer
MD446G2 (en) * 1995-07-07 1996-11-30 Онкологический Институт Республики Молдова Method for mamma cancer treatment
MD798G2 (en) * 1996-11-15 1998-05-31 Онкологический Институт Республики Молдова Method of the mamma cancer treatment
MD1569G2 (en) * 1999-12-17 2001-06-30 Онкологический Институт Республики Молдова Method of treatment of breast canceeeer in the preoperation period

Also Published As

Publication number Publication date
MD2849G2 (en) 2006-04-30

Similar Documents

Publication Publication Date Title
RU2016102158A (en) APPLICATION OF ERIBULIN AND LENVATINIB AS A COMBINED THERAPY FOR TREATMENT OF CANCER
RU2014128513A (en) CANCER MARKER AND THERAPEUTIC TARGET
BR112021022216A2 (en) 6-(2,4-Dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7] acid ]annulene-2-carboxylic acid for use in patients with metastatic or advanced breast cancer
MY208941A (en) Methods of treating cancer
EA201101651A1 (en) CONTINUOUS INTRODUCTION OF INTEGRINE LIGANDS FOR CANCER TREATMENT
MD2849F1 (en) Method of mammary cancer treatment to patients of old age
Burris et al. Pharmacokinetics (PK) of LOXO-101 during the first-in-human phase I study in patients with advanced solid tumors: Interim update
MD3772F1 (en) Method for treating mammary cancer with metastases
Laing et al. Malignant melanoma in renal transplant recipients
Hollebecque et al. Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients
Czito et al. A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma
RU2016143220A (en) ANTI-TUMOR AGENT CONTAINING AN ANTUMOR PLATINUM COMPLEX, AND ANTITUM AN EFFECT AMPLIFIER
SE0401066D0 (en) Chemical Derivatives
Chaminade Panniculitis and arthralgia: 3 case reports
Geneste et al. Bcl-2 selective antagonists show antitumor activity without dose limiting platelet toxicity
Gay et al. Cholecystokinin receptor antagonist proglumide reverses nonalcoholic steatohepatitis and prevents hepatocellular carcinoma
Gordeeva et al. The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
Chen Targeting osteosarcoma with graphene oxide-associated anti-HER2 antibodies
Mayer et al. A phase I study of vandetanib and metronomic chemotherapy in advanced breast cancer.
Taguchi Capecitabine/phenytoin interaction
PT1748770E (en) Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
WO2020076274A2 (en) Development of unique caffeic acid phenethyl ester molecules that are candidates for being cancer drugs and determining biological activities thereof
Kim et al. Benzyl isothiocyanate inhibits tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in a BALB/c mouse xenograft model
Ohgami Erlotinib/phenytoin interaction
Sakaguchi Peripheral neuropathy and myalgia: 2 case reports

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees